Drug Pipeline

Belinostat Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
3
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
4
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06561048 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral… Peripheral T-Cell Lymphoma, Not Otherwise Specified Recruiting
Phase 2
NCT04747236 Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's… PTCL Recruiting
NCT06406465 A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity Carcinoma, Neuroendocrine Recruiting
NCT05170334 Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma Metastatic Uveal Melanoma Active, Not Recruiting
NCT04340843 Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the… Locally Advanced Unresectable Primary Central Chondrosarcoma Active, Not Recruiting
Phase 1
NCT05154994 Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma Infiltrating Urothelial Carcinoma, Sarcomatoid Variant Active, Not Recruiting
NCT05627245 Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With… Recurrent B-Cell Non-Hodgkin Lymphoma Active, Not Recruiting
Sponsors Running Belinostat Trials
National Cancer Institute (NCI) (3) University of Virginia (1) University of Utah (1) H. Lee Moffitt Cancer Center and Research Institute (1) Corvus Pharmaceuticals, Inc. (1)
Disease Areas
Sarcoma (2) Bladder Cancer (1) Melanoma (1) Non-Hodgkin Lymphoma (1) DLBCL (1) Follicular Lymphoma (1)
Get alerts when Belinostat trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free